Jpmorgan Chase & CO Molecular Templates, Inc. Transaction History

Jpmorgan Chase & CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.33 - $12.0 $753 - $27,408	-2,284 Reduced 79.22%	599 $0
Q3 2022 Nov 14, 2022	BUY	$0.68 - $11.25 $422 - $6,997	622 Added 27.51%	2,883 $2,000
Q2 2022 Aug 11, 2022	SELL	$0.81 - $3.43 $193,398 - $818,957	-238,763 Reduced 99.06%	2,261 $2,000
Q1 2022 May 11, 2022	SELL	$2.27 - $4.13 $4,272 - $7,772	-1,882 Reduced 0.77%	241,024 $832,000
Q4 2021 Feb 10, 2022	SELL	$3.37 - $6.87 $48,881 - $99,649	-14,505 Reduced 5.63%	242,906 $952,000
Q3 2021 Nov 12, 2021	BUY	$5.78 - $7.86 $1.49 Million - $2.02 Million	257,411 New	257,411 $1.73 Million

499K

Ticker MTEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,351,600
Market Cap $10.1M
Description
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.